Persistent Asset Partners’s Cidara Therapeutics CDTX Stock Holding History

Persistent Asset Partners’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,704	Closed	-$1.04M	–	356
2025 Q4	$1.04M	Buy	+4,704	New	+$760K	0.47%	58

Persistent Asset Partners's CDTX Position: Q1 2026 in Review

Persistent Asset Partners sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 4,704 shares — an estimated $1.04M sold.

Persistent Asset Partners first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.04M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Persistent Asset Partners reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Persistent Asset Partners sold 4,704 Cidara Therapeutics shares in Q1 2026, an estimated $1.04M.
Persistent Asset Partners first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Persistent Asset Partners's Cidara Therapeutics position peaked at $1.04M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.